Individualized Hormone Replacement Therapy Versus Ovarian Transplantation

Journal Title: World Journal of Gynecology & Womens Health (WJGWH) - Year 2019, Vol 1, Issue 5

Abstract

Numerous studies conclude that risks and benefits of hormonal replacement therapy (HRT) are dose-dependent [1]. The pharmaceutical industry attempted to partially resolve the issue of individualization of HRT by manufacturing at least six different types of Minivelle patches (0.024mg, 0.0375mg, 0.05mg, 0.075mg, and 0.1mg). The choices offered by the pharmaceuticals are useful but fail to caliber dose based on the needs of the individual patient.Each woman and her physician must decide whether ERT is an appropriate option for her. When making this decision, it is important to consider three factors that affect the risk-benefits of ERT: age at initiation, hormone dose, and route of administration [1]. Estrogen deficiency over a period of many years may result in significant, changes such as bone loss, vaginal and bladder atrophy, and/or other symptoms [1,2]. Therefore, the earlier after menopause ERT is initiated, the better the long-term outcome [1].

Authors and Affiliations

Petrikovsky BM

Keywords

Related Articles

Ovarian Granulosa Cell Tumors: A Retrospective Study of 21 Cases and a Review of the Literature

Background: Granulosa cell tumors are rare tumors with a relatively favorable prognosis. The aim of this study was to report the epidemiologic, anatomo-clinical characteristics and to determine treatment modalities and s...

Individualized Hormone Replacement Therapy Versus Ovarian Transplantation

Numerous studies conclude that risks and benefits of hormonal replacement therapy (HRT) are dose-dependent [1]. The pharmaceutical industry attempted to partially resolve the issue of individualization of...

Achieving Tumor Free Margins: Intraoperative Pathology Consultation to Lower Re-Excision Rates at a Community Hospital

Objective: Achieving tumor free margins in a single surgery is the primary goal for breast conserving therapy (BCT). It is not uncommon for these patients to undergo more than one operation for positive margins. Within o...

Placenta Percreta Presenting as an Acute Abdomen in Second Trimester of Pregnancy: Case Report from Middle East

Abnormal Placentation carries life-threatening consequences to the mother. Placenta percreta is a rare complication of pregnancy. It occurs mostly in the third trimester and presents with severe postpartum...

Chromosome 16 Mutations and Congenital Genitourinary Malformations

Posterior urethral valve (PUV) disorder is an obstructive anomaly of the genitourinary tract. Found only in males, this condition is caused by an obstructing membrane in the posterior...

Download PDF file
  • EP ID EP609294
  • DOI 10.33552/WJGWH.2019.01.000525
  • Views 56
  • Downloads 0

How To Cite

Petrikovsky BM (2019). Individualized Hormone Replacement Therapy Versus Ovarian Transplantation. World Journal of Gynecology & Womens Health (WJGWH), 1(5), 1-2. https://europub.co.uk/articles/-A-609294